Vegan Omega-3 DHA Softgels (Gelatin-free) |
DEVA Vegan Omega-3 DHA is a quality product derived from algae and packaged in non-animal softgels made from tapioca starch. This makes a great non-animal alternative to DHA derived from fish and can be confidently used by vegetarians and vegans alike.
The typical Western diet may not provide sufficient amounts of DHA and vegans may be particularly prone to diets low in long chain omega-3 fatty acids (i.e. DHA & EPA) unless they are careful*.
DHA is a long chain polyunsaturated omega-3 oil. It is an essential fatty acid, meaning that the body doesn't produce it in significant amounts by itself and it or its precursors must be obtained in the diet. DHA is one of the prominent essential fatty acids in the brain and in the retina.
The algae oil used in our product is extracted from the algae without the use of hexane. The Omega-3 DHA oil used in this product comes from microalgae which has been grown on land (outside of the ocean) using drinkable water. The softgels are made from non-animal materials as well.*
DEVA Omega-3 DHA is 100% vegan, vegetarian and is registered by the Vegan Society, the non-profit organization that actually invented the word "vegan".
Supplement Facts Serving Size: 1 Vegan Softgel Serving Per Container: 90 Amount Per Serving % Daily Value* | Calories | 5 -- | | | Calories From Fat | 5 -- | | | Total Fat | 0.5 g 1% | Microalgae Oil (40% DHA) which typically provides: | 500 mg * | DHA (Docosahexaenoic acid) [Ω-3] | 200 mg * | | | *Daily Value not Established +Percent Daily Value are based on a 2000 calorie diet. | |
Other Ingredients: Non-gmo tapioca starch, vegetable glycerin, mid-oleic sunflower oil, purified water, mixed tocopherols, lemon oil; less than 1% of: canola oil, annatto color, rosemary extract, ascorbic acid. (All from non-animal sources)
For adults, take one (1) Vegan softgel daily with food, or as directed by a health care professional.
Free of yeast, wheat, soy, carrageenan, gluten, sugar, salt, hexane, dairy, egg, fish, shellfish; animal products, byproducts or derivatives.
Always consult your doctor before taking any dietary supplement.
*Information and statements regarding dietary supplements on our website have not been evaluated by the Food and Drug Administration and our products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. By using this site, you signify your assent to this Terms of Use Agreement. If you do not agree to the terms and conditions contained in this Terms of Use Agreement , you may not access or otherwise use this site and its contents.
*Walser B, Stebbins CL. “Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise.” Eur J Appl Physiol. 2008 Jun 18.
*Sidhu KS. “Health benefits and potential risks related to consumption of fish or fish oil.” Regul Toxicol Pharmacol. 2003 Dec;38(3):336-44.
*Lauritzen, L. et al. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res, 2001. 40:1-94.
* Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I, Decsi T, Dudenhausen JW, Dupont C, Forsyth S, Hoesli I, Holzgreve W, Lapillonne A, Putet G, Secher NJ, Symonds M, Szajewska H, Willatts P, Uauy R. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. Journal of Perinatal Medicine. 2008;36(1):5-14.
* Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: A review of human studies. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2007;76:189-203.
* Specker, B. et al. Differences in fatty acid composition of human milk in vegetarian and nonvegetarian women: long-term effect of diet. J Pediatr Gastroent Nutr, 1987. 6:764-8.
* Heude B, et al. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr, 2003.
* Salem N Jr, et al. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids, 2001. 36:945-59.
